{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:55:53Z","timestamp":1790614553969,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bmc.2018.05.031","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T12:44:26Z","timestamp":1526993066000},"page":"3573-3579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Facilely accessible quinoline derivatives as potent antibacterial agents"],"prefix":"10.1016","volume":"26","author":[{"given":"Peng","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderschouw","family":"Anne Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alekhya","family":"Nimmagadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2018.05.031_b0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1099\/jmm.0.043513-0","article-title":"Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus","volume":"61","author":"Watkins","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.bmc.2018.05.031_b0010","article-title":"MRSA may kill more US citizens than HIV","volume":"335","year":"2007","journal-title":"BMJ (Br Med J)"},{"key":"10.1016\/j.bmc.2018.05.031_b0015","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","article-title":"Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999\u20132005","volume":"13","author":"Klein","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmc.2018.05.031_b0020","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/JB.187.7.2426-2438.2005","article-title":"Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain","volume":"187","author":"Gill","year":"2005","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bmc.2018.05.031_b0025","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-resistant Enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2018.05.031_b0030","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of clostridium difficile\u2013associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2018.05.031_b0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2018.05.031_b0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","article-title":"Antibiotic-associated diarrhea","volume":"346","author":"Bartlett","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2018.05.031_b0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.idc.2014.11.003","article-title":"The morbidity, mortality, and costs associated with Clostridium difficile infection","volume":"29","author":"Kwon","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bmc.2018.05.031_b0050","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2018.05.031_b0055","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/JCM.02250-16","article-title":"Update on antimicrobial resistance in Clostridium difficile: resistance mechanisms and antimicrobial susceptibility testing","volume":"55","author":"Peng","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bmc.2018.05.031_b0060","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/jamainternmed.2013.9763","article-title":"Health care\u2013associated infections: a meta-analysis of costs and financial impact on the us health care system","volume":"173","author":"Zimlichman","year":"2013","journal-title":"JAMA Internal Med"},{"key":"10.1016\/j.bmc.2018.05.031_b0065","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1002\/anie.201209979","article-title":"Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials","volume":"52","author":"O'Connell","year":"2013","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmc.2018.05.031_b0070","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1021\/acs.jmedchem.6b00640","article-title":"Small antimicrobial agents based on acylated reduced amide scaffold","volume":"59","author":"Teng","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.05.031_b0075","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmc.2018.05.031_b0080","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/acs.jmedchem.6b01403","article-title":"Symmetrically substituted xanthone amphiphiles combat Gram-positive bacterial resistance with enhanced membrane selectivity","volume":"60","author":"Lin","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.05.031_b0085","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1021\/acs.jmedchem.6b00726","article-title":"Antibacterial and solubility optimization of thiomuracin A","volume":"59","author":"LaMarche","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.05.031_b0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2018.05.031_b0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1574-6976.2010.00247.x","article-title":"Quinolones: from antibiotics to autoinducers","volume":"35","author":"Heeb","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmc.2018.05.031_b0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: an update","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bmc.2018.05.031_b0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jac\/dkg222","article-title":"Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection","volume":"51","author":"Ruiz","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2018.05.031_b0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/jm401204g","article-title":"Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines","volume":"57","author":"Lam","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.05.031_b0115","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1128\/AAC.01321-06","article-title":"In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase\/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups","volume":"51","author":"Huband","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2018.05.031_b0120","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/jm9903500","article-title":"Structure\u2013activity relationships of novel 2-substituted quinazoline antibacterial agents","volume":"42","author":"Kung","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.05.031_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsps.2012.03.002","article-title":"Quinoline: a versatile heterocyclic","volume":"21","author":"Marella","year":"2013","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.bmc.2018.05.031_b0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bmc.2018.05.031_b0135","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa0808427","article-title":"The diarylquinoline TMC207 for multidrug-resistant tuberculosis","volume":"360","author":"Diacon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2018.05.031_b0140","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.bmc.2009.02.026","article-title":"Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis","volume":"17","author":"Upadhayaya","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.05.031_b0145","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.bmc.2009.01.013","article-title":"Synthesis and in vitro antitubercular activity of a series of quinoline derivatives","volume":"17","author":"de Souza","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.05.031_b0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1054\/tube.2002.0328","article-title":"Is Mycobacterium tuberculosis a closer relative to Gram-positive or Gram\u2013negative bacterial pathogens?","volume":"82","author":"Fu","year":"2002","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bmc.2018.05.031_b0155","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/S0960-894X(00)00542-4","article-title":"Potent In vitro methicillin-resistant Staphylococcus aureus activity of 2-(1H-indol-3-yl)quinoline derivatives","volume":"10","author":"Hoemann","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2018.05.031_b0160","unstructured":"He LCH, Zhou Q, Pan X. Preparation of quinoline derivatives as antitumor agents. C.N. Patent 101362719A Feb 11; 2009."},{"key":"10.1016\/j.bmc.2018.05.031_b0165","first-page":"879","article-title":"Daptomycin, a lipopeptide antibiotic in clinical practice","volume":"9","author":"Weis","year":"2008","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2018.05.031_b0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MOG.0b013e3283411634","article-title":"Update on Clostridium difficile infection","volume":"27","author":"O\u2019Donoghue","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bmc.2018.05.031_b0175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1469-0691.2011.03571.x","article-title":"The economic burden of Clostridium difficile","volume":"18","author":"McGlone","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bmc.2018.05.031_b0180","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2018.05.031_b0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/13543784.2010.495386","article-title":"Future novel therapeutic agents for Clostridium difficile infection","volume":"19","author":"Koo","year":"2010","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2018.05.031_b0190","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","article-title":"Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea","volume":"38","author":"Barbut","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bmc.2018.05.031_b0195","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/pgmj.2004.028480","article-title":"Pathogenesis and treatment of Clostridium difficile infection","volume":"81","author":"Tonna","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bmc.2018.05.031_b0200","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria","author":"Hecht","year":"2007"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618307259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618307259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:56:31Z","timestamp":1760835391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089618307259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0968089618307259"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2018.05.031","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facilely accessible quinoline derivatives as potent antibacterial agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2018.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}